Overview of Whitfield
| Property | Description |
|---|---|
| Active Ingredients | Benzoic Acid and Salicylic Acid |
| Form | Ointment (semisolid) or Solution (Tincture) |
| Pharmacological Class | Topical Antifungal and Keratolytic Agent |
| Common Use | Management of superficial skin conditions |
| Origin | Synthetic Organic Acids |
What Type of Medicine is Whitfield's Ointment and Its Classification?
Whitfield's Ointment, also known formally as Compound Benzoic Acid Ointment, is a classic and foundational topical combination product in dermatological practice, intended exclusively for external use only. It is classified primarily as a Topical Antifungal and a Keratolytic Agent, reflecting its strategic dual-action mechanism. This categorization signifies its integrated function of both limiting microbial proliferation and aiding the removal of damaged skin layers. As a pharmacopeial standard, this combination approach has been clinically recognized for its efficacy against superficial skin issues, distinguishing it from newer monotherapies.
Composition and Available Forms: Benzoic and Salicylic Acid
- The core active ingredients are the synthetic organic acids, Benzoic Acid and Salicylic Acid (INN), which are the essential components defining the product's function.
- The medicine is most frequently prepared as a semisolid Ointment, where the active ingredients are incorporated into an oleaginous base suitable for topical administration. Its enduring popularity is reflected by its inclusion on the WHO Model List of Essential Medicines.
High-Level Purpose: Combining Antifungal and Exfoliating Action
The general purpose of this topical preparation is to manage the skin environment through a synergistic attack on surface issues. Benzoic Acid provides a fungistatic action that helps deter microbial growth, while Salicylic Acid acts as a keratolytic agent, promoting the gentle, controlled shedding of affected outer skin layers. This dual approach ensures the medicine addresses the microbial component while simultaneously normalizing the skin's surface, which improves the overall access and effectiveness of the therapeutic agents.
Regulatory References

